Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons

This publication has 96 references indexed in Scilit:

• Olanzapine compared to quetiapine in adolescents with a first psychotic episode
  European Child & Adolescent Psychiatry, 2009
• A Non-randomized, Open Study with Aripiprazole and Ziprasidone for the Treatment of Aggressive Behavior in Youth in a Community Clinic
  Community Mental Health Journal, 2008
• Childhood Body-Mass Index and the Risk of Coronary Heart Disease in Adulthood
  New England Journal of Medicine, 2007
• The Level of Cardiovascular Risk Factors in Bipolar Disorder Equals That of Schizophrenia
  The Journal of Clinical Psychiatry, 2007
• Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003–2004
  Current Medical Research and Opinion, 2006
• Open-Label, 8-Week Trial of Olanzapine and Risperidone for the Treatment of Bipolar Disorder in Preschool-Age Children
  Biological Psychiatry, 2005
• Clinical effectiveness of new generation antipsychotics in adolescent patients
  European Neuropsychopharmacology, 2004
• Relation of Serial Changes in Childhood Body-Mass Index to Impaired Glucose Tolerance in Young Adulthood
  New England Journal of Medicine, 2004
• Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
  Diabetes Care, 2004
• Correlation of Antipsychotic and Prolactin Concentrations in Children and Adolescents Acutely Treated with Haloperidol, Clozapine, or Olanzapine
  Journal of Child and Adolescent Psychopharmacology, 2002